World Polio Day 2021 highlights progress and ongoing commitment to end polio everywhere
There’s been incredible progress in the efforts to eradicate polio everywhere. Currently, 5 out of 6 WHO regions are certified free of wild polio.
Despite the progress, there is still a way to go and although it is rare, cases of wild or vaccine-derived strain can become emergent in polio-free regions, including those countries that have not seen cases of polio for decades.
This demonstrates the importance of ensuring that every child is protected through immunisation. A fully immunised population is protected against both vaccine-derived and wild poliovirus.
पूरा लेख पढ़ने के लिए नीचे दिए गए लिंक का अनुसरण करें:
World Polio Day 2021 highlights progress and ongoing commitment to end polio everywhere
TGA approves booster doses of the Pfizer COVID-19 vaccine, COMIRNATY
The Therapeutic Goods Administration (TGA) has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
The TGA approval means that the Pfizer COVID-19 vaccine has been found safe and effective to boost protection for individuals aged 18 years and older through a booster dose provided at least six months after the completion of a COVID-19 vaccine primary course of two doses. The primary course can be of any of the COVID-19 vaccine registered for use in Australia.
Further advice on the use of boosters will be provided to government shortly by the Australian Technical Advisory Group on Immunisation (ATAGI).
बयान को पूरा पढ़ने के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
TGA approves booster doses of the Pfizer COVID-19 vaccine, COMIRNATY
बच्चों का नेटवर्क बढ़ाना - किशोरों के लिए नया COVID-19 टीकाकरण संसाधन
MVEC के साथ भागीदारी की है बच्चों का नेटवर्क बढ़ाना 12 साल और उससे अधिक उम्र के किशोरों को टीकाकरण के लिए COVID-19 वैक्सीन सिफारिशें प्रदान करने पर केंद्रित एक नया संसाधन विकसित करना।
यह लेख खुराक, सुरक्षा, प्रभावकारिता, दुष्प्रभाव और सुई फोबिया से निपटने के तरीके सहित किशोरों को प्रतिरक्षित करने के लिए प्रमुख कारकों को संबोधित करता है।
इस लेख को देखने के लिए नीचे दिए गए लिंक का अनुसरण करें:
बच्चों और किशोरों के लिए COVID-19 टीकों के बारे में अधिक जानकारी नीचे हमारे प्रतिरक्षण संदर्भ पृष्ठ के माध्यम से प्राप्त की जा सकती है:
MVEC: बच्चों में COVID-19 टीकाकरण
New educational resource: Generation Next course on COVID and kids
MVEC has collaborated with the team at Generation Next on a new resource featuring Dr Daryl Cheng to provide helpful strategies to get kids back to school safely and reduce transmission of COVID-19 in this group.
Course content reflects the combined efforts of immunisation paediatricians, adult physicians, immunisation nurses, infectious disease, and allergy specialists, as well as infection control teams. The information works to provide guidance and support for parents and communities to ensure a safe transition to a new COVID normal.
To enrol in this free course, please click on the link below:
Next Generation course: Covid and kids
Registrations now open for the Clinical Vaccinology Update (CVU) 2021!
Registrations are now open for the Clinical Vaccinology Update (CVU) 2021 which is taking place virtually on Thursday 18th and Friday 19th November.
This 2-day virtual program will allow participants to choose from keynote sessions delivered on our virtual main stage in addition to themed seminars and interactive workshops hosted by industry experts, addressing the most important issues in immunisation.
Register now and don’t miss this opportunity to hear the latest insights and learnings from leading immunisation professionals!
कार्यक्रम के बारे में और जानने के लिए और रजिस्टर करने के लिए, कृपया हमारे ईवेंट पेज के नीचे दिए गए लिंक पर क्लिक करें।
MVEC: Clinical Vaccinology Update (CVU) 2021
नया संसाधन: चिकित्सा छूट के लिए चर्चा मार्गदर्शिका
विक्टोरिया में COVID-19 टीकाकरण आवश्यकताओं के कारण, एक नया संसाधन चिकित्सा छूट के लिए एक चर्चा मार्गदर्शिका इस प्रक्रिया में चिकित्सकों का समर्थन करने के लिए बनाया गया है।
यह चर्चा मार्गदर्शिका सामान्य चिकित्सकों और अन्य स्वास्थ्य पेशेवरों के लिए है जो टीकों के बारे में बातचीत में शामिल हो सकते हैं और टीकाकरण के लिए चिकित्सा छूट प्रदान करने के लिए अधिकृत हैं। यह वैक्सीन संचार, डी-एस्केलेशन और नैदानिक अनुभव में अनुसंधान द्वारा सूचित किया गया है।
यदि आवश्यक हो तो यह शोध किसी भी संघर्ष के प्रबंधन के लिए उपयोगी वार्तालाप युक्तियाँ और रणनीतियाँ प्रदान करता है।
आप चर्चा मार्गदर्शिका तक पहुंच सकते हैंयहाँ।
चिकित्सा छूट के बारे में अधिक जानकारी के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
एमवीईसी: विक्टोरिया में कोविड-19 अनिवार्य टीकाकरण निर्देश
National Immunisation Program: Shingles vaccination catch-up program extended
The Department of Health has extended the shingles (herpes zoster) vaccine catch-up program available under the National Immunisation Program for a further 2 years until 31 October 2023.
The program extension will allow those who missed or delayed vaccination due to pandemic restrictions or other reasons, extra time to get vaccinated with Zostavax® to protect against shingles disease.
Shingles vaccination with the Zostavax® vaccine is free under the National Immunisation Program for people aged 70. The catch-up program offered to people aged 71-79 years was due to end on 31 October 2021.
To read the full announcement, please click on the link below.
National Immunisation Program: Shingles vaccination catch-up program extended
Submitting a referral to VicSIS has changed
The Victorian Specialist Immunisation Services (VicSIS) network has launched a new eReferral system. This new centralised referral and triaging system will allow for a more timely review of adults and children who have experienced an adverse event following immunisation (AEFI) with a COVID-19 vaccine.
This new referral pathway replaces the previous practice of emailing written referrals through to individual clinics.
For more information and to access the new eReferral system, please click on the link below:
MVEC: Victorian Specialist Immunisation Services (VicSIS) eReferral system
Provisional determination granted to Pfizer's COVID-19 vaccine (COMIRNATY) - for use in children 5-11 years of age
The Therapeutic Goods Administration (TGA) has granted provisional determination to Pfizer’s COVID-19 vaccine, Comirnaty™ as part of an application process to lower the approved age limit of vaccine administration from 12 years and above, to children 5 to 11 years.
Provisional determination is the first step in the provisional registration pathway. The provisional pathway for registration provides a formal and transparent mechanism for speeding up the registration of promising new medicines based on preliminary clinical data. Having provisional determination does not mean that provisional registration will be granted.
अधिक पढ़ने के लिए नीचे दिए गए लिंक का अनुसरण करें:
Provisional determination granted to Pfizer's COVID-19 vaccine (COMIRNATY) - for use in children 5-11 years of age
A recording is now available from The Alfred’s community information session on COVID-19 vaccinations and fertility
A webinar recording is now available from The Alfred’s community information session on COVID-19 vaccinations and fertility which was held on Thursday 7 October.
In this session, Alfred Health Infectious diseases physician and immunisation expert Prof Michelle Giles is joined by A/Prof Kate Stern, Head of Reproductive Services at The Royal Women's Hospital to discuss vaccination and fertility. They explain in detail how the vaccines work and answer questions from the community around fertility issues.
The full recording is available via the link below:
The Alfred community discussion 7 October